BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18498286)

  • 21. Anaplastic oligodendroglioma with ganglioglioma-like maturation.
    Tanaka Y; Nobusawa S; Yagi S; Ikota H; Yokoo H; Nakazato Y
    Brain Tumor Pathol; 2012 Oct; 29(4):221-8. PubMed ID: 22231405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell?
    Matsumura N; Yokoo H; Mao Y; Yin W; Nakazato Y
    Neuropathology; 2013 Jun; 33(3):246-55. PubMed ID: 23025580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis.
    Burel-Vandenbos F; Benchetrit M; Miquel C; Fontaine D; Auvergne R; Lebrun-Frenay C; Cardot-Leccia N; Michiels JF; Paquis-Flucklinger V; Virolle T
    J Neurooncol; 2011 Apr; 102(2):171-8. PubMed ID: 20652725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunocytochemical basis for a meningeo-glial network.
    Mercier F; Hatton GI
    J Comp Neurol; 2000 May; 420(4):445-65. PubMed ID: 10805920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas.
    Okada M; Yano H; Hirose Y; Nakayama N; Ohe N; Shinoda J; Iwama T
    Brain Tumor Pathol; 2011 Apr; 28(2):157-61. PubMed ID: 21312066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrastructural characteristics of glial fibrillary acidic protein expression in epoxy resin-embedded human brain tumors.
    Bozóky B; Krenács T; Rázga Z; Erdös A
    Acta Neuropathol; 1993; 86(3):295-301. PubMed ID: 8213089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas.
    Ohnishi A; Sawa H; Tsuda M; Sawamura Y; Itoh T; Iwasaki Y; Nagashima K
    J Neuropathol Exp Neurol; 2003 Oct; 62(10):1052-9. PubMed ID: 14575240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
    Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
    Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Observation on oligodendroglioma with light, electron microscopy and immunohistochemistry].
    Hang Z; Chen D; Wei Y
    Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):346-8. PubMed ID: 10374324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
    Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
    Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
    Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
    J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines.
    Reifenberger G; Bilzer T; Seitz RJ; Wechsler W
    Acta Neuropathol; 1989; 78(3):270-82. PubMed ID: 2475009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells.
    Blümcke I; Becker AJ; Normann S; Hans V; Riederer BM; Krajewski S; Wiestler OD; Reifenberger G
    J Neuropathol Exp Neurol; 2001 Oct; 60(10):984-93. PubMed ID: 11589429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytologic diagnosis of a metastatic oligodendroglioma in a pleural effusion. A case report.
    Lee CC; Jiang JS; Chen ET; Yokoo H; Pan YH; Tsai MD
    Acta Cytol; 2006; 50(5):542-4. PubMed ID: 17017442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
    Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
    Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro identification and functional characterization of glial precursor cells in human gliomas.
    Colin C; Baeza N; Tong S; Bouvier C; Quilichini B; Durbec P; Figarella-Branger D
    Neuropathol Appl Neurobiol; 2006 Apr; 32(2):189-202. PubMed ID: 16599947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The distribution of glial fibrillary acidic protein and protein S-100 in experimental brain tumors in rats].
    Khalanskiĭ AS; Shevchenko GM; Berezin VA
    Zh Vopr Neirokhir Im N N Burdenko; 1991; (1):19-22. PubMed ID: 1649519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructural pathology of glial brain tumors revisited: a review.
    Liberski PP; Kordek R
    Ultrastruct Pathol; 1997; 21(1):1-31. PubMed ID: 9029763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low grade diffuse gliomas: shared cellular composition and morphometric differences.
    Kinjo S; Hirato J; Nakazato Y
    Neuropathology; 2008 Oct; 28(5):455-65. PubMed ID: 18282166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies of experimental oligodendroglioma with special reference to the ultrastructure and immunohistochemical localization of S-100 protein, GFA protein and galactocerebroside (author's transl)].
    Takahashi K
    No To Shinkei; 1981 Jul; 33(7):703-14. PubMed ID: 7272099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.